NYSE:BAX

Baxter International Stock Forecast, Price & News

$80.69
+0.18 (+0.22 %)
(As of 07/23/2021 10:33 AM ET)
Add
Compare
Today's Range
$80.51
$81.10
50-Day Range
$80.27
$84.09
52-Week Range
$74.79
$91.45
Volume13,780 shs
Average Volume2.44 million shs
Market Capitalization$40.57 billion
P/E Ratio38.79
Dividend Yield1.40%
Beta0.68
30 days | 90 days | 365 days | Advanced Chart
Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.


Baxter International logo

About Baxter International

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.07 out of 5 stars

Medical Sector

52nd out of 2,216 stocks

Surgical & Medical Instruments Industry

4th out of 181 stocks

Analyst Opinion: 2.3Community Rank: 2.7Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Baxter International (NYSE:BAX) Frequently Asked Questions

Is Baxter International a buy right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Baxter International stock.
View analyst ratings for Baxter International
or view top-rated stocks.

What stocks does MarketBeat like better than Baxter International?

Wall Street analysts have given Baxter International a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Baxter International wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Baxter International
.

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, July 29th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) released its earnings results on Wednesday, April, 28th. The medical instruments supplier reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.64 by $0.12. The medical instruments supplier had revenue of $2.95 billion for the quarter, compared to analyst estimates of $2.89 billion. Baxter International had a trailing twelve-month return on equity of 18.34% and a net margin of 9.04%. The business's revenue was up 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.82 earnings per share.
View Baxter International's earnings history
.

How has Baxter International's stock price been impacted by Coronavirus?

Baxter International's stock was trading at $77.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BAX shares have increased by 3.3% and is now trading at $80.51.
View which stocks have been most impacted by COVID-19
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Monday, July 12th. Stockholders of record on Friday, September 3rd will be given a dividend of $0.28 per share on Friday, October 1st. This represents a $1.12 annualized dividend and a yield of 1.39%. The ex-dividend date is Thursday, September 2nd.
View Baxter International's dividend history
.

Is Baxter International a good dividend stock?

Baxter International pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.40%. Baxter International has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Baxter International is 36.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Baxter International will have a dividend payout ratio of 27.72% next year. This indicates that Baxter International will be able to sustain or increase its dividend.
View Baxter International's dividend history.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its FY 2021 earnings guidance on Thursday, May, 6th. The company provided earnings per share guidance of 3.470-3.550 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.400. The company issued revenue guidance of $12.61 billion-$12.72 billion, compared to the consensus revenue estimate of $12.53 billion.

What price target have analysts set for BAX?

12 brokers have issued 1 year price targets for Baxter International's stock. Their forecasts range from $85.00 to $98.00. On average, they expect Baxter International's stock price to reach $89.80 in the next year. This suggests a possible upside of 11.5% from the stock's current price.
View analysts' price targets for Baxter International
or view top-rated stocks among Wall Street analysts.

Who are Baxter International's key executives?

Baxter International's management team includes the following people:
  • Mr. Jose E. Almeida, Chairman, Pres & CEO (Age 59, Pay $1.37M)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 48, Pay $1.08M)
  • Mr. Sean B. W. Martin, Sr. VP & Gen. Counsel (Age 58, Pay $943.45k)
  • Mr. Giuseppe Accogli, Sr. VP and Pres of Americas & Global Bus. Units (Age 50, Pay $1.09M)
  • Mr. Cristiano Franzi, Sr. VP & Pres for EMEA (Age 58, Pay $1.33M)
  • Mr. Brian C. Stevens, Sr. VP, Chief Accounting Officer & Controller (Age 46)
  • Dr. Sumant Ramachandra, Pres of Pharmaceuticals and Sr. VP, Chief Science & Technology Officer (Age 52)
  • Mr. Talvis P. Love, Sr. VP & Chief Information Officer
  • Ms. Clare Trachtman, VP of Investor Relations
  • Ms. Stacey Eisen, Sr. VP of Global Communications

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International CEO José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among Baxter International's employees.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Abbott Laboratories (ABT), The Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Palisade Asset Management LLC (0.02%), New Mexico Educational Retirement Board (0.01%), TIAA FSB (0.01%), Raymond James Trust N.A. (0.00%), Gofen & Glossberg LLC IL (0.00%) and Connolly Sarah T. (0.00%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends for Baxter International
.

Which major investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including First United Bank Trust, and Raymond James Trust N.A.. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Andrew Frye, James R Gavin III, and John D Forsyth.
View insider buying and selling activity for Baxter International
or view top insider-selling stocks.

Which major investors are buying Baxter International stock?

BAX stock was bought by a variety of institutional investors in the last quarter, including TIAA FSB, Palisade Asset Management LLC, New Mexico Educational Retirement Board, Stock Yards Bank & Trust Co., Gofen & Glossberg LLC IL, Vigilant Capital Management LLC, and Connolly Sarah T..
View insider buying and selling activity for Baxter International
or or view top insider-buying stocks.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $80.51.

How much money does Baxter International make?

Baxter International has a market capitalization of $40.48 billion and generates $11.67 billion in revenue each year. The medical instruments supplier earns $1.10 billion in net income (profit) each year or $3.09 on an earnings per share basis.

How many employees does Baxter International have?

Baxter International employs 50,000 workers across the globe.

Does Baxter International have any subsidiaries?

The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..

When was Baxter International founded?

Baxter International was founded in 1931.

What is Baxter International's official website?

The official website for Baxter International is www.baxter.com.

Where are Baxter International's headquarters?

Baxter International is headquartered at One Baxter Parkway DF2-1W, Deerfield IL, 60015.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


This page was last updated on 7/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.